计算溶液所需的质量、体积或浓度。
,适用于对基线干扰要求严格的色谱和分析工作流程。
室温。 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
•Broad Institute在578种人类癌细胞系中测试了4518种药物,发现大量非肿瘤药物可以选择性地抑制癌细胞系的亚群(PMID:32613204);
•802种经过博德研究所验证具有抗癌活性的化合物的独特集合,适用于高通量筛选(HTS)和高内涵筛选(HCS);
•靶点包括DNA/RNA Synthesis,HDAC,EGFR,Aurora激酶,拓扑异构酶等;
•某些化合物已被FDA批准;
•结构多样,具有药用活性且可渗透细胞;
•提供丰富的文档信息,包括化合物结构和生物活性信息;
•验证NMR和HPLC以确保高纯度
详细信息
|
•The Broad Institute tested 4,518 drugs across 578 human cancer cell lines and found large number of non-oncology drugs selectively inhibited subsets of cancer cell lines(PMID:32613204)
•A unique collection of 802 compounds with anticancer activity which has been verified by broad institute used for high throughput screening(HTS) and high content screening(HCS)
•Targets DNA/RNA Synthesis, HDAC, EGFR, Aurora Kinase, Topoisomerase, etc.
•Some compounds have been approved by the FDA
•Structurally diverse,medicinally active,and cell permeable
•Rich documentation with structure and bioactivity information
•NMR and HPLC validated to ensure high purity
Product Details
| |||||||||||||||||||
Anti-cancer Compound Library-Ⅱ Composition
